MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Molecular Interventions 6:311-314, (2006)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.6.6.4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGehee, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGehee, D. S.

Viewpoint

Nicotinic and Opioid Receptor Interactions in Nicotine Addiction

Daniel S. McGehee

Department of Anesthesia and Critical Care, University of Chicago, 5841 S. Maryland Avenue, MC4028, Chicago, IL 60637

SUMMARY

Many addictive drugs, including nicotine, increase the expression of opioid receptors and endogenous opioid peptides. How nicotinic receptors mediate this change in opioid signaling and its functional significance in the etiology of nicotine addiction remain unknown. Opioid and nicotinic receptor biology in the context of behaviors associated with drug dependence is discussed. Indeed, findings on the interactions between these receptor systems and recent studies on human behavior lead to the interesting suggestion that variants in the opioid receptor structure might predict the success of smoking cessation treatment.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.